Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Hasbani in a Visit to Jebbit Bsharri: We Believe in Transparency and Work to Improve the Performance of Institutions and the Role of the Private and Governmental Hospitals

 
NNA – Deputy Prime Minister Health Minister Ghassan Hasbani visited Jebbit Bsharri accompanied by the Director of his office Michel Aad, Counselors Frederic Eid and Georges Akoury. His first stop was in Al-Arz Medical Center in Qanat where he was greeted by Deputies Sethrida Geagea and Elie Keyrouz, the Lebanese Forces Candidate for the district Joseph Isaac, Head of the Municipality Federation in the District Elie Makhlouf, Head of Qanat Municipality Dr. Antoine Saadeh, members of the Municipality Council and Mayors, President of Cedars Medical Association Rita Garana, the Lebanese Forces coordinators, Heads of centers in Jebbit Bshari, President of Qanat Dispensary Zeina El Alam, member of the Lebanese Dental Association council Joseph El Hayek and a number of Lebanese forces activists , people from the region and nearby villages.
 
Hasbani then announced “the launch of the pilot phase for the telemedicine project that connects the primary healthcare centers to the University hospitals, while providing a gatekeeper model for the health system and high-quality services for the remote villages.” Hasbani also noted the aids granted by the World Bank and UNICEF in this context.

“ We are introducing today from this place this new initiative for the telemedicine pilot phase through electronic devices. This is the first in its kind in Lebanon and the Middle East. This project enables citizens in the healthcare centers in the remote villages to undergo more than 16 medical examinations, and communicate directly with specialist doctors in University Hospitals in Beirut. In the future, they will be able to communicate with specialist doctors abroad, in the event that their case is incurable in Lebanon”, Hasbani said.

Hasbani then headed to Hadath el Jebbeh, before he moved with Geagea and Keyrouz to St. Daniel Dispensary and Hasroun, where he visited the dispensary and the new building of Mar Mema Hospital in Bsharri.

“We believe in transparency and work hard to improve the performance of institutions and the role of Governmental and private hospitals. Our 2025 health strategy includes the introduction of technology in hospitals and the Universal health Coverage for all the citizens, in particular uninsured people.”
 
    1
ATC Name B/G Ingredients Dosage Form ↑ Price
A10BB12 JOSWE GLEMAX 2 G Glimepiride - 2mg 2mg Caplet 139,760 L.L
A10BB12 JOSWE GLEMAX 3 G Glimepiride - 3mg 3mg Caplet 235,172 L.L
A10BB12 JOSWE GLEMAX 4 G Glimepiride - 4mg 4mg Caplet 235,172 L.L
A10BB12 JOSWE GLEMAX 6 G Glimepiride - 6mg 6mg Caplet 663,858 L.L
C10AA05 JOSWE ATORVAST 10 G Atorvastatin - 10mg 10mg Caplet, film coated 849,308 L.L
C10AA05 JOSWE ATORVAST 20 G Atorvastatin - 20mg 20mg Caplet, film coated 956,816 L.L
C10AA05 JOSWE ATORVAST 40 G Atorvastatin - 40mg 40mg Caplet, film coated 1,327,716 L.L
C10BX03 JOSWE DUBARA 5/10 G Amlodipine - 5mg, Atorvastatin - 10mg Caplet, film coated 2,370,538 L.L
C10BX03 JOSWE DUBARA 10/10 G Amlodipine - 10mg, Atorvastatin - 10mg Caplet, film coated 2,655,433 L.L
A02BC03 JOSWE LANZOTEC 30 G Lansoprazole - 30mg 30mg Capsule 271,456 L.L
A02BC03 JOSWE LANZOTEC 30 G Lansoprazole - 30mg 30mg Capsule 514,692 L.L
A02BC03 JOSWE LANZOTEC 15 G Lansoprazole - 15mg 15mg Capsule 270,112 L.L
M01AH01 JOSWE FLAMEX 200 G Celecoxib - 200mg 200mg Capsule 225,766 L.L
M01AH01 JOSWE FLAMEX 200 G Celecoxib - 200mg 200mg Capsule 636,981 L.L
M01AH01 JOSWE FLAMEX 400 G Celecoxib - 400mg 400mg Capsule 585,915 L.L
M01AH01 JOSWE FLAMEX 400 G Celecoxib - 400mg 400mg Capsule 1,400,284 L.L
D06BB10 JEDARA G Imiquimod - 5% 5% Cream 3,850,109 L.L
D11AX11 JOLITE FORTE CREAM G Hydroquinone - 4% 4g/100g Cream 612,792 L.L
L01CD04 JEVTANA INJECTION B Cabazitaxel - 60mg/1.5ml 60mg/1.5ml Injectable dry powder for solution+diluent 75,619,931 L.L
L01CD04 JEVTANA INJECTION B Cabazitaxel - 60mg/1.5ml 60mg/1.5ml Injectable dry powder for solution+diluent 75,619,931 L.L
A10AB01 JUSLINE R BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable solution 401,809 L.L
B03BA01 JECTIN-12 G Cyanocobalamin - 1000mcg/1ml 1000mcg/1ml Injectable solution 567,102 L.L
A10AD01 JUSLINE BioTech Insulin (human) - 100IU/ml 100IU/ml Injectable suspension 401,809 L.L
A10AE01 JUSLINE N BioTech Insulin human isophane - 100IU/ml 100IU/ml Injectable suspension 401,809 L.L
J01CR02 JULMENTIN 2X G Amoxicillin (trihydrate) - 400mg/5ml, Clavulanic Acid (potassium) - 57mg/5ml 457mg/5ml Powder for suspension 278,175 L.L
J01CR02 JULMENTIN ES G Amoxicillin (trihydrate) - 600mg/5ml, Clavulanic Acid (potassium) - 42.9mg/5ml 642.9mg/5ml Powder for suspension 507,972 L.L
R05CA12 JOS-PAN G Dried Ivy leaf extract (Hederacoside C) - 75mg/100ml Syrup 306,396 L.L
N05AH04 JOSWE QUZAL 25 G Quetiapine - 25mg 25mg Tablet 258,018 L.L
N05AH04 JOSWE QUZAL 25 G Quetiapine - 25mg 25mg Tablet 490,503 L.L
M03BX08 JAMP-CYCLOBENZAPRINE G Cyclobenzaprine HCl - 10mg 10mg Tablet 4,031,528 L.L
    1
Sitemap
© Copyrights reserved to Ministry of Public Health 2026